367 related articles for article (PubMed ID: 15175835)
21. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography.
Herder GJ; van Tinteren H; Golding RP; Kostense PJ; Comans EF; Smit EF; Hoekstra OS
Chest; 2005 Oct; 128(4):2490-6. PubMed ID: 16236914
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
[TBL] [Abstract][Full Text] [Related]
23. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.
Fletcher JW; Kymes SM; Gould M; Alazraki N; Coleman RE; Lowe VJ; Marn C; Segall G; Thet LA; Lee K;
J Nucl Med; 2008 Feb; 49(2):179-85. PubMed ID: 18199626
[TBL] [Abstract][Full Text] [Related]
25. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Naalsund A; Maublant J
Respiration; 2006; 73(5):634-41. PubMed ID: 16679755
[TBL] [Abstract][Full Text] [Related]
26. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
Farid K; Poullias X; Alifano M; Regnard JF; Servois V; Caillat-Vigneron N; Petras S
Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging.
Bury T; Dowlati A; Paulus P; Corhay JL; Benoit T; Kayembe JM; Limet R; Rigo P; Radermecker M
Eur Respir J; 1996 Mar; 9(3):410-4. PubMed ID: 8729997
[TBL] [Abstract][Full Text] [Related]
28. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
[TBL] [Abstract][Full Text] [Related]
29. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
[TBL] [Abstract][Full Text] [Related]
30. PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.
Sim YT; Goh YG; Dempsey MF; Han S; Poon FW
Lung; 2013 Dec; 191(6):625-32. PubMed ID: 24013495
[TBL] [Abstract][Full Text] [Related]
31. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
[TBL] [Abstract][Full Text] [Related]
33. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y
Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581
[TBL] [Abstract][Full Text] [Related]
34. [Comparative analysis of integrated (99m)Tc-MIBI-SPECT/localizable CT and integrated ¹⁸F-FDG-PET/CT for differential diagnosis of solitary pulmonary nodules].
Deng Z; Li G; Xiang X; Jia L; Liu C; Chen T; Liu C
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):422-6. PubMed ID: 25818793
[TBL] [Abstract][Full Text] [Related]
35. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.
Sathekge MM; Maes A; Pottel H; Stoltz A; van de Wiele C
S Afr Med J; 2010 Sep; 100(9):598-601. PubMed ID: 20822650
[TBL] [Abstract][Full Text] [Related]
36. The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT.
Zhao M; Chang B; Wei Z; Yu H; Tian R; Yuan L; Jin H
World J Surg Oncol; 2015 Sep; 13():271. PubMed ID: 26369407
[TBL] [Abstract][Full Text] [Related]
37. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
Lohrmann C; Weber WA
Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199
[TBL] [Abstract][Full Text] [Related]
38. The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.
Macdonald K; Searle J; Lyburn I
Clin Radiol; 2011 Mar; 66(3):244-50. PubMed ID: 21295203
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT.
Aquino SL; Kuester LB; Muse VV; Halpern EF; Fischman AJ
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):692-6. PubMed ID: 16514531
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
